
Phase I clinical trials of Biological Response zzso must be designed to provide information not only regarding zzso zzso and zzso response, but also on their many zzso zzso If zzso are to be used rationally, then detailed standardized data must be obtained in such a way as to enable meaningful conclusions to be drawn from the monitoring zzso zzso selection, timing for monitoring and methods for data interpretation are important considerations in the design of such zzso 

